Placebo News and Research

RSS

Early patient response to Forteo in postmenopausal women with osteoporosis

Changes in markers of bone remodeling after one month of treatment with FORTEO® (teriparatide [rDNA origin] injection) may provide important early evidence of treatment response, according to new data presented today at the 86th Annual Meeting of The Endocrine Society (ENDO).

17 Jun 2004

Regular use of beta-agonist drugs for asthma could be endangering their patients

Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

17 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

New research findings presented this week in New Orleans during ENDO 2004, the 86th Annual Meeting of The Endocrine Society, could help keep kids healthier.

16 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Pulsed dye laser therapy not effective in treating acne

Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.

16 Jun 2004

Echinacea may do nothing for that runny nose

Some think echinacea is nothing to sneeze at. Others aren't convinced of the claims that the herb can fight the common cold. A study in the May 15 issue of Clinical Infectious Diseases, now available online, adds to the evidence against the herb's alleged powers: In the study, echinacea did not prevent a common cold virus from infecting volunteers.

15 Jun 2004

Calcium supplements can decrease the risk of all types of colorectal polyps

While taking calcium supplements can decrease the risk of all types of colorectal polyps, research led by Dartmouth Medical School shows calcium had the greatest effect on advanced colorectal adenomas, considered to be most strongly associated with invasive colorectal cancer.

15 Jun 2004

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis, but it has no effect on alertness and cognitive function, says a new Oregon Health & Science University study.

11 Jun 2004

New treatment significantly improves long-term outlook for breast cancer survivors

An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.

11 Jun 2004

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

In this trial, REMICADE provided a 70 percent improvement (as measured by ACR 70) in symptoms of arthritis in nearly one-third of patients, compared with only 2 percent of patients on placebo at 24 weeks.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.

7 Jun 2004

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Research presented today showed that the investigational drug, LAF237, the first in a new class, improved glycemic control in patients with type 2 diabetes. In this study, LAF237, which is administered as a tablet to be taken orally, was added to the standard diabetes treatment metformin in patients whose diabetes was not adequately controlled by metformin alone.

7 Jun 2004

Treatment with atorvastatin cut incidence of stroke by almost a half

Patients with Type 2 diabetes and a CV risk factor would benefit from a cholesterol-lowering medicine according to results from the first ever specifically designed UK primary prevention statin trial announced today at the American Diabetes Association (ADA)2.

7 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.

3 Jun 2004

Contradictory views on the use of Prozac to treat children with depression

A new US Government study suggests that anti-depressants such as Eli Lilly and Co's Prozac are the best way to treat children with depression.

3 Jun 2004

Placebo News and Research

Early patient response to Forteo in postmenopausal women with osteoporosis

Regular use of beta-agonist drugs for asthma could be endangering their patients

Intrinsa patch increases sexual desire in menopausal women

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

Results from study of Rituxan in rheumatoid arthritis show promise

Pulsed dye laser therapy not effective in treating acne

Echinacea may do nothing for that runny nose

Calcium supplements can decrease the risk of all types of colorectal polyps

Cannabis extract drug may help patients with rheumatoid arthritis

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis

New treatment significantly improves long-term outlook for breast cancer survivors

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Drug may benefit patients suffering deep scarring after radiation treatment

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Treatment with atorvastatin cut incidence of stroke by almost a half

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Contradictory views on the use of Prozac to treat children with depression

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News